Javascript must be enabled to continue!
Elements and Evolutionary Determinants of Genomic Divergence Between Paired Primary and Metastatic Tumors
View through CrossRef
ABSTRACT
Can metastatic-primary (M-P) genomic divergence measured from next generation sequencing reveal the natural history of metastatic dissemination? This remains an open question of utmost importance in facilitating a deeper understanding of metastatic progression, and thereby, improving its prevention. Here, we utilize mathematical and computational modeling to tackle this question as well as to provide a framework that illuminates the fundamental elements and evolutionary determinants of M-P divergence. Our framework facilitates the integration of sequencing detectability of somatic variants, and hence, paves the way towards bridging the measurable between-tumor heterogeneity with analytical modeling and interpretability. We show that the number of somatic variants of the metastatic seeding cell that are experimentally undetectable in the primary tumor, can be characterized as the path of the phylogenetic tree from the last appearing variant of the seeding cell back to the most recent detectable variant. We find that the expected length of this path is principally determined by the decay in detectability of the variants along the seeding cell’s lineage; and thus, exhibits a significant dependence on the underlying tumor growth dynamics. A striking implication of this fact, is that dissemination from an advanced detectable subclone of the primary tumor can lead to an abrupt drop in the expected measurable M-P divergence, thereby breaking the previously assumed monotonic relation between seeding time and M-P divergence. This is emphatically verified by our single cell-based spatial tumor growth simulation, where we find that M-P divergence exhibits a non-monotonic relationship with seeding time when the primary tumor grows under branched and linear evolution. On the other hand, a monotonic relationship holds when we condition on the dynamics of progressive diversification, or by restricting the seeding cells to always originate from undetectable subclones. Our results highlight the fact that a precise understanding of tumor growth dynamics is the
sine qua non
for exploiting M-P divergence to reconstruct the chronology of metastatic dissemination. The quantitative models presented here enable further careful evaluation of M-P divergence in association with crucial evolutionary and sequencing parameters.
Graphical Abstract
Highlights
Depth of most recent detectable variant characterizes Metastatic-Primary divergence
Decay in variant detectability determines the expected M-P divergence
Dissemination from late detectable subclone leads to an abrupt drop in M-P divergence
Spatial model verifies growth mode governs M-P divergence dependency on seeding time
Title: Elements and Evolutionary Determinants of Genomic Divergence Between Paired Primary and Metastatic Tumors
Description:
ABSTRACT
Can metastatic-primary (M-P) genomic divergence measured from next generation sequencing reveal the natural history of metastatic dissemination? This remains an open question of utmost importance in facilitating a deeper understanding of metastatic progression, and thereby, improving its prevention.
Here, we utilize mathematical and computational modeling to tackle this question as well as to provide a framework that illuminates the fundamental elements and evolutionary determinants of M-P divergence.
Our framework facilitates the integration of sequencing detectability of somatic variants, and hence, paves the way towards bridging the measurable between-tumor heterogeneity with analytical modeling and interpretability.
We show that the number of somatic variants of the metastatic seeding cell that are experimentally undetectable in the primary tumor, can be characterized as the path of the phylogenetic tree from the last appearing variant of the seeding cell back to the most recent detectable variant.
We find that the expected length of this path is principally determined by the decay in detectability of the variants along the seeding cell’s lineage; and thus, exhibits a significant dependence on the underlying tumor growth dynamics.
A striking implication of this fact, is that dissemination from an advanced detectable subclone of the primary tumor can lead to an abrupt drop in the expected measurable M-P divergence, thereby breaking the previously assumed monotonic relation between seeding time and M-P divergence.
This is emphatically verified by our single cell-based spatial tumor growth simulation, where we find that M-P divergence exhibits a non-monotonic relationship with seeding time when the primary tumor grows under branched and linear evolution.
On the other hand, a monotonic relationship holds when we condition on the dynamics of progressive diversification, or by restricting the seeding cells to always originate from undetectable subclones.
Our results highlight the fact that a precise understanding of tumor growth dynamics is the
sine qua non
for exploiting M-P divergence to reconstruct the chronology of metastatic dissemination.
The quantitative models presented here enable further careful evaluation of M-P divergence in association with crucial evolutionary and sequencing parameters.
Graphical Abstract
Highlights
Depth of most recent detectable variant characterizes Metastatic-Primary divergence
Decay in variant detectability determines the expected M-P divergence
Dissemination from late detectable subclone leads to an abrupt drop in M-P divergence
Spatial model verifies growth mode governs M-P divergence dependency on seeding time.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Breast cancer biomarkers : dynamics during treatment and metastatic progression
Breast cancer biomarkers : dynamics during treatment and metastatic progression
<p dir="ltr">Breast cancer is a major global health challenge as incidence is increasing, and risk of recurrence remains a significant concern for long-term survivors. In an ...
Breast cancer biomarkers : dynamics during treatment and metastatic progression
Breast cancer biomarkers : dynamics during treatment and metastatic progression
<p dir="ltr">Breast cancer is a major global health challenge as incidence is increasing, and risk of recurrence remains a significant concern for long-term survivors. In an ...
Abstract 3716: The origin of metastatic ovarian tumors: A national population-based analysis
Abstract 3716: The origin of metastatic ovarian tumors: A national population-based analysis
Abstract
Objective: A significant part of ovarian malignancies are metastatic tumors with a wide variety in site of origin. Differentiating between a primary and met...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 2155: Genetics of Primary and Metastatic Ovarian Cancer
Abstract 2155: Genetics of Primary and Metastatic Ovarian Cancer
Abstract
Objective:
The purpose of this study is to determine the differential copy number abnormalities (CNA) in primary serous epithelial ovarian ca...

